SENEXON-S

Manufacturer
H.J. Harkins Company, Inc. | RUGBY LABORATORIES, INC. | TIME-CAP LABS, INC
Effective date
2011-12-29
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 22:30:28

Label at a glance#

ProductSENEXON-S
Active ingredientdocusate sodium, sennosides a and b
Label structure14 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active ingredients (in each tablet)

Docusate sodium 50 mg

Sennosides 8.6 mg

OTC - ASK DOCTOR SECTION

ASK A DOCTOR BEFORE USE IF YOU HAVE A SUDDEN CHANGE IN BOWEL HABITS THAT LASTS OVER TWO WEEKS

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist berfore use if you are taking any other drug.  Laxatives may affect how other drugs work.

WARNINGS SECTION

Do not use if your are taking mineral oil; for longer than one week; when abdominal pain, nausea or vomiting are present

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - PURPOSE SECTION

Uses:  relieves occasional constipation; generally produces bowel movement in  6-12 hours.

OTC - QUESTIONS SECTION

call 1 800 645-2158 9 am - 5 pm Monday - Friday

OTC - STOP USE SECTION

Stop use and ask a doctor if: you have rectal bleeding; you fail to have a bowel movement after use of this product.  These may indicate a serious condition.

INACTIVE INGREDIENT SECTION

  Inactive ingredients

carnauba wax, colloidal silicon dioxide, croscarmellose sodium

D-C yellow #10 aluminum lake, dibasic calcium phosphate

dihydrate, FD-C yellow #6 aluminum lake, hypromellose,

magnesium stearate, microcrystalline cellulose, polyethylene

glycol, sodium benzoate, stearic acide, Titanium dioxide

OTC - WHEN USING SECTION

Directions take preferably at bedtime or as directed by a doctor

If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maxiumum dosage)


DOSAGE & ADMINISTRATION SECTION

Dosage and Administration

Adults and children 12 years and over - 2 tablets once a day - maximum dosage - 4 tablets twice a day

children 6 to under 12 years - 1 tablet once a day maximum dosage - 2 tablets twice a day

children 2 to under 6 years - 1/2 tablet once a day - maximum dosage- 1 tablet twice a day

children under 2 years - ask a doctor

INDICATIONS & USAGE SECTION

RELIEVES OCCASIONAL CONSTIPATION

GENERALLY PRODUCES BOWEL MOVEMENT IN 6-12 HOURS

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

labellabelEnter section text here

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1248013Senexon-S 50 MG / 8.6 MG Oral TabletPSN2
998740sennosides 8.6 MG / docusate sodium 50 MG Oral TabletPSN2
1248013docusate sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]SBD2
998740docusate sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSCD2
998740DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral TabletSY2
1248013DOSS Sodium 50 MG / sennosides, USP 8.6 MG Oral Tablet [Senexon S]SY2
1248013Senexon-S (docusate sodium 50 MG / sennosides, USP 8.6 MG) Oral TabletSY2

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
52959-675-00SENEXON-S100 in 1 BOTTLE, PLASTICTABLET, COATED1002
52959-675-02SENEXON-S120 in 1 BOTTLE, PLASTICTABLET, COATED1202
52959-675-08SENEXON-S180 in 1 BOTTLE, PLASTICTABLET, COATED1802
52959-675-30SENEXON-S30 in 1 BOTTLE, PLASTICTABLET, COATED302
52959-675-60SENEXON-S60 in 1 BOTTLE, PLASTICTABLET, COATED602

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
52959-675SENEXON-S (DOCUSATE SODIUM -SENNOSIDES ) TABLET, COATED [H.J. HARKINS COMPANY, INC.]2Legacy NDC, 5 package rows20111230_f6e923e8-46e8-4287-bd62-5b954829cd73.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
52959-675-00EA - Each52959-6759d585c77-9f1c-48ae-87fe-bc9c38bc598512012-07-24
52959-675-02EA - Each52959-675910aae5c-3cba-41c5-aefa-a56c03f4562b12012-07-24
52959-675-08EA - Each52959-675e85449e5-15c3-438a-8c8d-beeee061dd0312012-07-24
52959-675-30EA - Each52959-675019b1af6-9251-4611-bfc8-27c629f5a08b12012-07-24
52959-675-60EA - Each52959-675ef13180d-db0d-48d4-babb-b11c54d938bc12012-07-24
0536-4086-01EA - Each0536-4086af38146a-a60f-4c1c-9038-38a930152ea612012-07-24
0536-4086-10EA - Each0536-4086eb55d6fe-9265-49bf-8f42-35b29c4f319f12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
docusate sodiumACTIVE INGREDIENTF05Q2T2JA02
sennosides a and bACTIVE INGREDIENT1B5FPI42EN2
docusateACTIVE MOIETYM7P27195AG2
sennosides a and bACTIVE MOIETY1B5FPI42EN2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52959-67552959-675-30, 52959-675-60, 52959-675-00, 52959-675-02, 52959-675-08
0536-4086

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
e57a4e72-fd3d-44fa-96ca-06ea1d477cc8f6e923e8-46e8-4287-bd62-5b954829cd732011-12-29WarningsExact identifier
spl id: e57a4e72-fd3d-44fa-96ca-06ea1d477cc8
spl set id: f6e923e8-46e8-4287-bd62-5b954829cd73

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.